¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÆó¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 KALC International Conference (1ÀÏÂ÷) : 2021-11-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÆó¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 KALC International Conference (1ÀÏÂ÷) : 2021-11-25
±³À°ÀÏÀÚ : 2021-11-25
±³À°Àå¼Ò : ¿Â¶óÀÎ Çмú´ëȸ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 KALC International Conference (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540  
À̸ÞÀÏ : kalc@lungca.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú      
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ08:00~08:50 Cancer Evolution and How Early Intervention May Improve Chance of Cure  Nicholas McGranahan(Univ. College London UK) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ08:50~09:10 Liquid Biopsy, What Is the Best Approach?  Pimpin Incharoen(Mahidol Univ. Thailand) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ09:10~09:30 Molecular Biomarker Testing for Non-Small Cell Lung Cancer: Consensus Statement of the Korean Cardiopulmonary Pathology Study Group  Sunhee Chang(Inje Univ) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ09:30~09:50 The Era of Personalized Medicine: How the Pathologist Can Make a Difference?  Philippe Joubert(Laval Univ. Canada) 
È޽Ġ11-25 ¿Â¶óÀΠ09:50~10:10 Coffee Break  () 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ10:10~10:35 How to Develop Credible, Useful Real-World Evidence Including Artificial Intelligence and Big Data Analytics  Brain D. Bradbury(Center for Observational Research at Amgen USA) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ10:35~11:00 Way of Real-World Evidence: Past, Present, and Future Opportunities in Korea  Ju-Young Shin(Sungkyunkwan Univ.) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ11:00~11:15 New Version of Tumor, Node, Metastasis (TNM) Staging  Hisao Asamura(Keio Univ. Japan) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ11:15~11:25 Domestic Lung Cancer Disease Investigation ProjectÅ×½ºÆ®  Ho Cheol Kim(Univ. of Ulsan) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ11:25~12:10 Recent Update of Checkmate 9LA and Checkmate 227, Pivotal Trials in 1L Non-Small Cell Lung Cancer  Manuel Cobo Dols(Hospital Regional Universitario Málaga Spain) 
½Ä»ç 11-25 ¿Â¶óÀΠ12:10~13:00 Lunch Break  () 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ13:00~13:25 Targeting mEGFR with 3rd Generation TKI  Se-Woong Oh(Yuhan Corporation) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ13:25~13:50 Targeting KRAS  David S. Hong(MD Anderson Cancer Center USA) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ13:50~14:15 Targeting Fusion Driver Mutation  Alice T. Shaw(Novartis USA) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ14:15~14:40 Challenges in the Use of Targeted Therapy in Non-Small Cell Lung Cancer  Alex A. Adjei(Mayo Clinic USA) 
È޽Ġ11-25 ¿Â¶óÀΠ14:40~15:00 Coffee Break  () 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ15:00~15:25 Subxiphoid Single Port VATS Thymectomy  Sukki Cho(Seoul National Univ.) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ15:25~15:50 Robotic Thymectomy  Chang Hyun Kang(Seoul National Univ.) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ15:50~16:15 Robotic Pulmonary Lobectomy  Giulia Veronesi(Humanitas Research Hospital Italy) 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ16:15~16:40 Single Port Robotic Thoracic Surgery   Seong Yong Park(Yonsei Univ) 
È޽Ġ11-25 ¿Â¶óÀΠ16:40~16:50 Coffee Break  () 
±³À°½Ã°£ 11-25 ¿Â¶óÀΠ16:50~17:40 The Role and the Current Status of Immunotherapy in Lung Cancer Treatment  Michael Holmes(MSD UK) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÆó¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 KALC International Conference (1ÀÏÂ÷) : 2021-11-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °ø°øÀÇ·á´Â °ø°øº´¿ø¸¸ÀÇ Àǹ«ÀÌ°í ¿ªÇÒÀΰ¡? ±× ³íÀï¿¡ ´ëÇÏ¿© : 2021-11-25
´ÙÀ½±Û °Ç°­º¸Çè ºòµ¥ÀÌÅÍ ÀÚ·áºÐ¼®À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥(2Â÷)(2ÀÏÂ÷) : 2021-11-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
258 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª : 2018-09-14 0 655 2018-07-28
257 ¼­¿ï »ï¼º¼­¿ïº´¿ø 2018 »ï¼º ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-14 0 673 2018-07-28
256 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2018 ÀÇ·áÇöÀå¿¡¼­ ¸¸³ª´Â ¾à¹°¾Ë·¹¸£±â : 2018-09-14 0 832 2018-07-28
255 ¼­¿ï »ï¼º¼­¿ïº´¿ø ¾ÓÄÚ¸£¼­¿ï 2018 : 2018-09-14 0 555 2018-07-28
254 ¼­¿ï ¼­¿ïƯº°½ÃÀÇ»çȸ °­ÀÇ(Àú½ÅÀåÄ¡·á, ¹æ»ç¼±Ä¡·á) : 2018-09-13 0 1,164 2018-07-28
253 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø 1) Á¡¸·Áúȯ 2) ÇǺΠ¸é¿ªÇÐ : 2018-09-13 0 840 2018-07-28
252 ¼­¿ï »ï¼º¼­¿ïº´¿ø ¾ÓÄÚ¸£¼­¿ï 2018 : 2018-09-13 0 451 2018-07-28
251 ºÎ»ê ´ëÇÑ°£ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2018-09-13 0 600 2018-07-28
250 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø ÀӽŠ¹× ¼öÀ¯±â°£ Áß ¾à¹° Ä¡·á : 2018-09-12 0 667 2018-07-28
249 Ãæ³² ´ëÇÑ°¡Á¤ÀÇÇÐȸ °»³â±â È£¸£¸ó Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-09-12 0 604 2018-07-28
248 ¼­¿ï »ï¼º¼­¿ïº´¿ø ¾ÓÄÚ¸£¼­¿ï 2018 : 2018-09-12 0 686 2018-07-28
247 ÀÎõ ÀÎÇÏ´ëÇб³º´¿ø ³ì³»ÀåȯÀÚÀÇ ¾à¹°Ä¡·á : 2018-09-11 0 406 2018-07-28
246 ÃæºÏ 2018³â ÃæºÏ´ëÇб³º´¿ø ºñ´¢ÀÇÇаú ¿¬¼ö°­Á : 2018-09-11 0 674 2018-07-28
245 ¼­¿ï ´ëÇѾȰúÇÐȸ ¼­¿ï ³²ºÎ Áöȸ ¿¬¼ö ±³À° : 2018-09-10 0 709 2018-07-28
244 ¼­¿ï Á¦ 1ȸ °­ºÏ»ï¼ºº´¿ø ¼Ò¾Æû¼Ò³â°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-09 0 765 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷